A1 Refereed original research article in a scientific journal

Suppression of TGF beta and Angiogenesis by Type VII Collagen in Cutaneous SCC




AuthorsMartins VL, Caley MP, Moore K, Szentpetery Z, Marsh ST, Murrell DF, Kim MH, Avari M, McGrath JA, Cerio R, Kivisaari A, Kahari VM, Hodivala-Dilke K, Brennan CH, Chen M, Marshall JF, O'Toole EA

PublisherOXFORD UNIV PRESS INC

Publication year2016

JournalJNCI: Journal of the National Cancer Institute

Journal name in sourceJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

Journal acronymJNCI-J NATL CANCER I

Article numberARTN djv293

Volume108

Issue1

Number of pages11

ISSN0027-8874

DOIhttps://doi.org/10.1093/jnci/djv293


Abstract

Conclusions: Type VII collagen suppresses TGF beta signaling and angiogenesis in cutaneous SCC. Patients with RDEB SCC may benefit from anti-angiogenic therapy.



Last updated on 2024-26-11 at 17:47